What are the recent outsourcing activities of Torrent Pharmaceuticals Limited with leading international companies?
Torrent Pharmaceuticals Ltd. has reached an agreement with Novartis Pharma AG, a leading international pharma company, based in Switzerland regarding global rights to its very early stage AGE (Advanced Glycosylation End products) breaker compound. AGE breakers are compounds with potential in the treatment of heart disease and diabetes related vascular complications.